Citrus Compound Hesperidin Protects Trigeminal Nerve and Reduces CGRP in Migraine Model
Hesperidin (a citrus flavonoid) protected against trigeminal nerve damage and reduced CGRP levels in a nitroglycerin-induced migraine model, suggesting a natural approach to CGRP modulation.
Quick Facts
What This Study Found
Hesperidin protected against trigeminal nerve damage and reduced CGRP levels in an NTG-induced migraine model, demonstrating a natural compound that modulates the CGRP migraine pathway.
Key Numbers
C57BL/6j mice used. Nitroglycerin (NTG) was used to induce the migraine model. TRPV1 channel was the primary target analyzed.
How They Did This
NTG (nitroglycerin)-induced migraine mouse model treated with hesperidin. Assessed trigeminal nerve histology, CGRP levels, and migraine behavioral markers.
Why This Research Matters
CGRP antibodies cost thousands per year. If natural compounds like hesperidin can reduce CGRP and protect trigeminal nerves, they could provide accessible, affordable complementary migraine management.
The Bigger Picture
Natural compounds that modulate CGRP could complement pharmaceutical anti-CGRP drugs. Hesperidin joins a growing list of natural CGRP modulators including magnesium, CoQ10, and riboflavin that may support migraine prevention through dietary or supplement approaches.
What This Study Doesn't Tell Us
Mouse migraine model. Hesperidin doses in mice may not translate to human dietary levels. Bioavailability of oral hesperidin is limited. Clinical migraine studies needed.
Questions This Raises
- ?Would hesperidin supplementation reduce migraine frequency in clinical trials?
- ?Is the CGRP reduction sufficient for meaningful migraine prevention in humans?
- ?Could hesperidin be combined with CGRP antibodies for enhanced effect?
Trust & Context
- Key Stat:
- Natural CGRP reduction Citrus-derived hesperidin reduced CGRP and protected trigeminal nerves in a migraine model — natural modulation of the same target as expensive antibody drugs
- Evidence Grade:
- Preliminary evidence: mouse migraine model demonstrating natural compound CGRP modulation. No human migraine data.
- Study Age:
- Published in 2025. Adds hesperidin to natural CGRP modulators for migraine.
- Original Title:
- The effect of hesperidin on trigeminal nerve damage in an NTG-induced migraine model: the role of the TRPV1 channel.
- Published In:
- Molecular biology reports, 53(1), 25 (2025)
- Database ID:
- RPEP-09790
Evidence Hierarchy
Frequently Asked Questions
Can citrus fruits help with migraines?
This mouse study shows hesperidin — found in oranges, lemons, and other citrus — reduces CGRP, the key migraine peptide, and protects trigeminal nerves. While human studies are needed, hesperidin supplements are being investigated as natural migraine support.
How does hesperidin compare to CGRP migraine drugs?
CGRP antibodies are far more potent and proven. Hesperidin is a much milder natural modulator. It might work as a complementary approach alongside conventional treatment, but cannot replace proven migraine medications for moderate-to-severe disease.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09790APA
Ahlatcı, Adem; Yıldızhan, Kenan; Keleş, Ömer Faruk; Bayir, Mehmet Hafit; Çınar, Ramazan. (2025). The effect of hesperidin on trigeminal nerve damage in an NTG-induced migraine model: the role of the TRPV1 channel.. Molecular biology reports, 53(1), 25. https://doi.org/10.1007/s11033-025-11194-8
MLA
Ahlatcı, Adem, et al. "The effect of hesperidin on trigeminal nerve damage in an NTG-induced migraine model: the role of the TRPV1 channel.." Molecular biology reports, 2025. https://doi.org/10.1007/s11033-025-11194-8
RethinkPeptides
RethinkPeptides Research Database. "The effect of hesperidin on trigeminal nerve damage in an NT..." RPEP-09790. Retrieved from https://rethinkpeptides.com/research/ahlatc-2025-the-effect-of-hesperidin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.